Evidence map›Paper›PMID 32090064›Full record

ArticleBioMed research international2019

Intracerebroventricular Coadministration of Protoxin-II and Trace Elements in Rats Enhances the Analgesic Effect of the 1.7 Voltage-Gate Sodium Channel Blocker.

Gabriela-Dumitrita Stanciu, Andrei Luca, Aurelia Marza, Teodora Alexa-Stratulat, Ionut Tudorancea, Walther Bild, Elena Rezus, Ciprian Rezus, Bogdan I Tamba

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Gabriela-Dumitrita StanciuCenter for Advanced Research and Development in Experimental Medicine (CEMEX), "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universitatii Street, Iaşi 700115, Romania.ORCID https://orcid.org/0000-0003-4440-9628
Andrei LucaCenter for Advanced Research and Development in Experimental Medicine (CEMEX), "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universitatii Street, Iaşi 700115, Romania.ORCID https://orcid.org/0000-0002-3628-4637
Aurelia MarzaDepartment of Physiology, "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universitatii Street, Iaşi 700115, Romania.
Teodora Alexa-StratulatDepartment of Medical Oncology-Radiotherapy, "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universitatii Street, Iaşi 700115, Romania.ORCID https://orcid.org/0000-0003-2696-9568
Ionut TudoranceaDepartment of Cardiology, "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universitatii Street, Iaşi 700115, Romania.
Walther BildDepartment of Physiology, "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universitatii Street, Iaşi 700115, Romania.
Elena RezusDepartment of Rheumatology and Physiotherapy, "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universitatii Street, Iaşi 700115, Romania.
Ciprian RezusDepartment of Internal Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universitatii Street, Iaşi 700115, Romania.
Bogdan I TambaCenter for Advanced Research and Development in Experimental Medicine (CEMEX), "Grigore T. Popa" University of Medicine and Pharmacy, 16 Universitatii Street, Iaşi 700115, Romania.ORCID https://orcid.org/0000-0001-9868-1999
Grigore T. Popa University of Medicine and Pharmacy · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pain continues to be a global unmet medical need, and the current recommendations for its management require a constant exploration of new drugs that target multiple pain mechanisms, with an improved safety profile and increased treatment adherence. Currently, the enriched distribution and localization within nociceptors of the selective channel blockers and the critical role played by sodium channels in neuronal excitability nominate isoforms as specific targets to generate innovative compounds. In the present report, we verified the hypothesis that coadministration of Protoxin-II, a selective sodium channel inhibitor, and trace elements has direct and improved antinociceptive effects. Groups of seven Wistar rats were treated intracerebroventricularly with a combination of MgCl

Indexed as

AnalgesicsAnimalsDisease Models, AnimalIon Channel GatingMaleNociceptionNociceptorsPainPain MeasurementPeptidesRatsRats, WistarSodium Channel BlockersSodium ChannelsSpider VenomsTrace ElementsAnalgesicsPeptidesSodium Channel BlockersSodium ChannelsSpider VenomsTrace Elements

Identifiers

PMID32090064
PMCPMC7024082
OpenAlexW2997610747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.